CAR T Cell Therapy for Chronic Lymphocytic Leukemia: Successes and Shortcomings

CAR T Cell Therapy for Chronic Lymphocytic Leukemia: Successes and Shortcomings

Chimeric antigen receptor T (CAR T) cell therapy achieved remarkable success in B-cell leukemia and lymphoma which led to its incorporation in treatment protocols for these diseases. CAR T cell therapy for chronic lymphocytic leukemia (CLL) patients showed less success compared to other malignant tu...

Full description

Bibliographic Details
Main Authors: Zeljko Todorovic, Dusan Todorovic, Vladimir Markovic, Nevena Ladjevac, Natasa Zdravkovic, Predrag Djurdjevic, Nebojsa Arsenijevic, Marija Milovanovic, Aleksandar Arsenijevic, Jelena Milovanovic
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Current Oncology
Subjects:
CAR T cells
CAR NK cells
CLL
Online Access:https://www.mdpi.com/1718-7729/29/5/293

Internet

https://www.mdpi.com/1718-7729/29/5/293

Similar Items